02171.HK
CARsgen Therapeutics Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 12.75
+3.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 19.32x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.76x
- Price / sales
- 46.08x
- Price / cash flow
- -132.69x
Enterprise value
- Enterprise value
- HKD 5.8B
- EV / sales
- 36.37x
- EV / EBITDA
- -22.90x
- EV / EBIT
- -50.26x
- Market cap
- HKD 7.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026